Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) Net Margin (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Net Margin for 4 consecutive years, with 5701.11% as the latest value for Q3 2025.

  • Quarterly Net Margin changed N/A to 5701.11% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 33603.33% through Dec 2025, changed N/A year-over-year, with the annual reading at 36987.78% for FY2025, N/A changed from the prior year.
  • Net Margin for Q3 2025 was 5701.11% at Actinium Pharmaceuticals, up from 21775.56% in the prior quarter.
  • The five-year high for Net Margin was 549.36% in Q1 2022, with the low at 34826.09% in Q4 2021.
  • Average Net Margin over 3 years is 10725.56%, with a median of 4228.88% recorded in 2021.
  • Peak annual rise in Net Margin hit 31430bps in 2022, while the deepest fall reached -1901890bps in 2022.
  • Over 3 years, Net Margin stood at 34826.09% in 2021, then surged by 37bps to 21775.56% in 2022, then surged by 74bps to 5701.11% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 5701.11%, 21775.56%, and 17444.44% for Q3 2025, Q3 2022, and Q2 2022 respectively.